Last Updated on October 9, 2024 by The Health Master
Gland Pharma said the US health regulator has issued a Form 483 with one observation after inspecting its Hyderabad-based facility.
The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) for seven products and good manufacturing practice (GMP) inspection at the company’s Pashamylaram facility in Hyderabad between June 15 and June 27, 2023, the drug firm said in a regulatory filing.
The inspection was concluded with one observation on Form 483, it added.
“This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA within the stipulated period,” Gland Pharma stated.
The observation issued is neither a repeated observation nor related to data integrity, it added.
As per US Food and Drug Administration (USFDA), Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
USFDA completes inspection at Ajanta Pharma with zero observations: Gujarat
USFDA concludes inspection at Zydus with zero observation
USFDA completes inspection of Dr Reddy’s with zero observation
USFDA issues Form 483 with 11 observations IPCA Labs: Ratlam
USFDA issues Form 483 with 4 observations to Aurobindo Pharma
USFDA issues Form 483 with zero observations to Pharma MSMEs: Gujarat
Prescribe generic medicines only: Health Dept
Export Promotion Council for Medical Devices added to Foreign Trade Policy
US Drug Shortages present growth opportunities for Indian Pharma Companies
USFDA completes inspection at Ajanta Pharma with zero observations: Gujarat
DTAB recommends ban on Ketoprofen and Aceclofenac for Animal
Irregularities in Medicine Sales: HM urges enhanced efficiency and technological integration
One held for allegedly storing 36,238 bottles of banned cough syrup
Understanding Airlock Systems in Pharma Industry
USFDA approves this drug to treat hair loss
DTAB: Proposal to restrict Nicotine Replacement Therapies Sales to Prescription Only
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
